Although the EML4-ALK fusion gene is a minor genetic abnormality in NSCLC [21], [22], the incidence of lung cancer is increasing in many countries, the absolute number of lung cancer patients harboring the EML4-ALK fusion gene is not trivial. The gene discussed is ALK; the disease is lung carcinoma.